Dose pulmonary hemorrhage increase the risk of bronchopulmonary dysplasia in very low birth weight infants?

DOI: https://doi.org/10.21203/rs.3.rs-2190757/v1

Abstract

Objective: To evaluate the association between pulmonary hemorrhage and bronchopulmonary dysplasia (BPD) in very low birth weight infants (VLBWIs). 

Methods: The study participants were all VLBW newborns admitted from January 1, 2019 to December 31, 2021. The finally included subjects were VLBWIs who survived to discharge. This study was divided into pulmonary hemorrhage group (PH group, n=33) and non-pulmonary hemorrhage group (Non-PH group, n=181). 

Results: By univariate analysis it was found that premature rupture of membranes, tracheal intubation in the delivery room, duration of mechanical ventilation, course of invasive ventilation (≥3 courses), pulmonary surfactant (>1 dose), medically and surgically treated patent ductus arteriosus, grade III-IV RDS, and early onset sepsis showed significant differences between groups (p<0.05). By univariate analysis, pulmonary hemorrhagedid not increase the risks of BPD and moderate to severe BPD. However, if the interference of invasive ventilation is excluded, pulmonary hemorrhage could increase the incidence of BPD (aOR=3.295, 95%CI1.183-9.179). 

Conclusion: Our data suggests that pulmonary hemorrhage is not associated with the development of BPD and moderate to severe BPD in VLBWIs.

1. Introduction

In recent years, with the increasing pregnancy rate at advanced maternal age and the improvement of assisted reproductive technology, premature infants are becoming more common. But, due to the immature lung development, many premature babies are prone to respiratory distress syndrome (RDS), apnea, pulmonary hemorrhage and other respiratory diseases, and often need mechanical ventilation [13]. Among them, because of smaller gestational age and lower birth weight, very low birth weight infants (VLBWIs) are vulnerable to pulmonary hemorrhage, which can result in respiratory failure, death and other chronic consequences [45].

So far, there has been continuous controversy about whether pulmonary hemorrhage could induce bronchopulmonary dysplasia (BPD) [67]. Li j et al carried out a single center retrospective study and found that moderate to severe BPD was significantly higher in the group with massive pulmonary hemorrhage (12/51 VLBWIs in the group with pulmonary hemorrhage vs 17/548 VLBWIs in the group without pulmonary hemorrhage, p < 0.05) [7]. However, Wang TT et al believed the opposite [8/30 extremely low birth weight infants (ELBWIs) in the pulmonary hemorrhage group vs 41/130 ELBWIs in the non-pulmonary hemorrhage group, p = 0.602] [6]. Based on the above contradictory views, this retrospective study was conducted to investigate whether pulmonary hemorrhage could increase the incidence of BPD in VLBWIs.

2. Patients And Methods

2.1. Preterm infants

This is a single center, retrospective cohort study.

(1) Inclusion criteria: The study participants were all VLBW newborns admitted to the neonatal intensive care unit (NICU) of Children's Hospital Affiliated to Nanjing Medical University from January 1, 2019 to December 31, 2021. The finally included subjects were VLBWIs who successfully survived to discharge.

(2) Exclusion criteria: Infants with serious congenital malformations, hereditary metabolic diseases and death during hospitalization were excluded. Newborns with incomplete information in the case report form (CRF) were also excluded.

(3) Diagnostic criteria: Pulmonary hemorrhage was defined as bright red blood secretion from the endotracheal tube that was associated with clinical deterioration, including increased ventilator support with a fraction of inspired oxygen (FiO2) increase of > 0.3 from the baseline [8] or an acute drop in hematocrit (> 10%) [9], in addition to multi-lobular infiltrates on chest radiography. RDS was defined according to the latest guideline − 2019 European Consensus Guidelines on the Management of Respiratory Distress Syndrome (ECGMRDS) [10]. Bronchopulmonary dysplasia (BPD) was defined and graded based on a requirement for oxygen at 36 weeks postmenstrual age (NHLBI/NICHD 2010) [11]. Retinopathy of prematurity (ROP) was defined and classified according to the papers published by the International Classification Committee on retinopathy of prematurity [12]. Intraventricular hemorrhage (IVH) was defined and classified according to the literature reported by Papile LA 1978 and Volpe JJ 2008 [1314]. Diagnostic criteria of necrotizing enterocolitis (NEC): NEC was defined and classified according to Bell’s stage [15]. Sepsis was defined based on Expert consensus on the diagnosis and management of neonatal (version 2019) [16].

(4) Exposure and grouping: The exposure factor was whether the infant had pulmonary hemorrhage during hospitalization. This study was consequently divided into pulmonary hemorrhage group (PH group) and non-pulmonary hemorrhage group (Non-PH group).

(5) Outcomes: The main outcome was the incidences of all BPD and moderate to severe BPD. The secondary outcomes were pneumothorax, IVH (≥ grade III), NEC (≥ grade II), ROP and length of hospital stay.

2.2. Clinical data and methods

(1) Clinical data: CRF data of all subjects were collected by two neonatologists and checked by a third person. Clinical data including maternal hypertension, maternal diabetes, amniotic fluid turbidity, prenatal glucocorticoid, birthweight, gestational age, gender, fetal distress, mode of delivery, Apgar score, history of resuscitation, invasive and non-invasive mechanical ventilation, use of caffeine and pulmonary surfactant (PS), RDS, medically and surgically treated PDA, sepsis, NEC (≥ stage II), IVH (≥ grade III), BPD during hospitalization.

(2) Postnatal resuscitation: Postnatal resuscitation of all VLBWIs was performed in accordance with the Chinese neonatal resuscitation guidelines [17]. After birth, newborns were given warm and positive pressure ventilation with mask, and subsequent respiratory support was provided by T-piece. The need for further endotracheal intubation is determined by the neonatologist in the delivery room [17]. After resuscitation, the patient was transferred to NICU for further assessment by the doctor on duty. Invasive or non-invasive ventilation was adopted, and surfactant was first supplemented according to the severity of RDS.

(3) Therapy for respiratory diseases: During the hospitalization, the attending physician decided on the application of invasive ventilation [synchronized intermittent mandatory ventilation (SIMV), synchronized intermittent positive pressure ventilation (SIPPV), high frequency oscillatory ventilation (HFOV)], extubation and non-invasive ventilation [nasal continuous positive airway pressure (nCPAP), nasal intermittent positive pressure ventilation (NIPPV), high flow nasal cannula (HFNC) and non-invasive high frequency oscillatory ventilation (nHFOV)]. The indications for endotracheal intubation in NICU were evaluated by two standards [18]. (1) Absolute indications: invasive ventilation is required for any of the following conditions: ① Repeated apnea; ② Partial pressure of carbon dioxide (PaCO2) > 60mmHg with persistent acidosis; ③ Partial pressure of oxygen (PaO2) < 50 ~ 60mmHg, inhaled oxygen concentration > 60%~70%. (2) Relative indications, in which invasive ventilation can be considered for any of the following situations: ① Intermittent apnea, which is ineffective for treatment; ② Severe dyspnea; ③ Blood gas analysis deteriorated sharply, PaCO2 increased and PaO2 decreased. The use of caffeine and repeated surfactants was also based on the 2019 ECGMRDS guidelines [10].

2.3. Statistical methods

Statistical analysis was performed using SPSS 13.0 software. For univariate analysis, quantitative data which obey normal distribution were showed as mean and standard deviation. Comparisons between the two groups were performed using t or t’ test. For skew distribution data, the median and interquartile range are used. Mann-Whitney test was used for comparison. In terms of qualitative data, Pearson Chi-square test was performed. For multivariate analysis, binary logistic regression analysis was used. We assessed the potential confounding variables in our statistical modeling if the p value of univariate analysis was less than 0.05. Adjusted odds ratio (aOR) with 95% confidence interval (CI) were then collected. p < 0.05 was considered statistically significant.

3. Results

3.1. Comparison of perinatal history between pulmonary hemorrhage group and non-pulmonary hemorrhage group:

From January 1, 2019 to December 31, 2021, 275 VLBWIs were hospitalized in our NICU, including 42 cases with pulmonary hemorrhage and 233 cases with non-pulmonary hemorrhage. After screening by inclusion and exclusion criteria, 214 VLBWIs were finally included in the study, including 33 survival cases in the pulmonary hemorrhage group and 181 survival cases in the non-pulmonary hemorrhage group (Fig. 1). The comparison between the groups showed that there were significant differences in premature rupture of membranes (PROM) and tracheal intubation in the delivery room (p < 0.05). Table 1.

 
Table 1

Comparison of perinatal history between pulmonary hemorrhage group and non-pulmonary hemorrhage group

 

PH group

(n = 33)

Non-PH group

(n = 181)

χ2/t

p value

Maternal data

       

Maternal age (Mean ± SD, years)

32.27 ± 6.30

30.57 ± 4.47

1.486

0.145

Full course of prenatal glucocorticoid # [n(%)]

7(21.2)

69(38.1)

3.485

0.062

Fetal distress [n(%)]

6(18.2)

12(6.6)

3.452

0.063

Amniotic fluid turbidity [n(%)]

3(9.1)

19(10.5)

0.000

1.000

Cesarean section [n(%)]

21(63.6)

90(49.7)

2.164

0.141

Maternal diabetes† [n(%)]

5(15.2)

26(14.4)

0.000

1.000

Maternal hypertension* [n(%)]

6(18.2)

25(13.8)

0.150

0.699

PROM > 18 hours [n(%)]

13(39.4)

16(8.8)

19.711

0.0009

Neonatal data

       

Tracheal intubation in the delivery room [n(%)]

24(72.7)

69(38.1)

13.603

0.0002

Apgar score at 1minute (Mean ± SD)

6.94 ± 1.83

6.49 ± 2.19

1.220

0.228

Apgar score at 5minute (Mean ± SD)

8.03 ± 1.26

7.90 ± 1.58

0.455

0.650

Birthweight (Mean ± SD, grams)

1165.15 ± 168.77

1185.30 ± 278.97

-0.401

0.689

Male [n(%)]

19(57.6)

103(56.9)

0.005

0.943

Gestational age (Mean ± SD, weeks)

29.29 ± 1.90

28.93 ± 1.79

1.028

0.305

Small for gestational age [n(%)]

5(15.2)

16(8.8)

0.644

0.422

#Prenatal glucocorticoid use refers to the full course of treatment / (those who have not applied and have not completed the full course of treatment). †Maternal diabetes includes diabetes in pregnancy and gestational diabetes. *Maternal hypertension refers to hypertensive disorders in pregnancy.

3.2. Comparison of main diagnosis and therapy for respiratory diseases between pulmonary hemorrhage group and non-pulmonary hemorrhage group

There were significant differences between the two groups in the main diagnosis, including medically and surgically treated PDA as well as grade III-IV RDS (p < 0.05). There were significant differences between the two groups in the use of surfactant, the duration and course of invasive ventilation (p < 0.05). Table 2.

 
Table 2

Comparison of main diagnosis and therapy for respiratory diseases between pulmonary hemorrhage group and non-pulmonary hemorrhage group

 

PH group

(n = 33)

Non-PH group

(n = 181)

χ2/Z

p value

Main diagnosis

       

Grade III-IV RDS [n(%)]

22(66.7)

31(17.1)

36.763

0.0001

Medically and surgically treated PDA [n(%)]

19(57.6)

38(21.0)

19.114

0.0001

Early onset sepsis [n(%)]

17(51.5)

25(13.8)

25.152

0.0005

Therapy for respiratory diseases

       

Use of surfactant [n(%)]

28(84.8)

140(77.3)

0.930

0.335

More than one dose of surfactant [n(%)]

24(72.7)

32(17.7)

43.776

0.0004

Duration of caffeine application (Median + quartile, days)

       

Duration of invasive ventilation (Median + quartile, days)

264(143, 528.5)

99(62.5, 192)

-4.496

0.0007

Duration of non-invasive ventilation (Median + quartile, days)

319(174.5, 688)

469.5(168, 744)

-0.257

0.789

Course of invasive ventilation(≥ 3 courses) [n(%)]

6(18.2)

7(3.9)

7.672

0.006

Course of non-invasive ventilation(≥ 3 courses) [n(%)]

6(18.2)

15(8.3)

2.071

0.150


3.3. Comparison of main outcomes between pulmonary hemorrhage group and non-pulmonary hemorrhage group

There were significant differences in BPD, moderate to severe BPD, IVH (≥ grade III) and length of hospital stay between groups (p < 0.05). Table 3.

 
Table 3

Comparison of main outcomes between pulmonary hemorrhage group and non-pulmonary hemorrhage group

 

PH group

(n = 33)

Non-PH group

(n = 181)

χ2/Z

p value

BPD [n(%)]

26(78.8)

98(54.1)

6.956

0.008

Moderate to severe BPD [n(%)]

16(61.5)

38(38.8)

4.331

0.037

Length of hospital stay (Median + quartile, days)

67.81 ± 21.99

56.48 ± 18.30

3.126

0.002

Pneumothorax [n(%)]

0(0.0)

0(0.0)

/

/

NEC (≥ grade II) [n(%)]

3(9.1)

11(6.1)

0.068

0.794

ROP [n(%)]

8(24.2)

23(12.7)

2.139

0.144

IVH (≥ grade III) [n(%)]

4(12.1)

3(1.7)

6.635

0.010


3.4. Multivariate logistic regression analysis between pulmonary hemorrhage and BPD

Variables with p < 0.05 in Table 1 and Table 2 (PROM, tracheal intubation in the delivery room, use of surfactant more than once, grade III-IV RDS, medically and surgically treated PDA, early onset sepsis, and duration and course of invasive ventilation) were included in the multivariable analysis as confounding factors. Considering the relationship between BPD and mechanical ventilation, two models were adopted. Model 1 included PROM, tracheal intubation in the delivery room, duration of mechanical ventilation, course of invasive ventilation (≥ 3 courses), more than one dose of PS, medically and surgically treated PDA, grade III-IV RDS, and early onset sepsis. Model 2 just included PROM, tracheal intubation in the delivery room, more than one dose of PS, medically and surgically treated PDA, grade III-IV RDS, and early onset sepsis. It was found that pulmonary hemorrhage did not increase the risks of BPD and moderate to severe BPD. However, if the interference of invasive ventilation is excluded, pulmonary hemorrhage could increase the incidence of BPD (aOR = 3.295, 95%CI1.183-9.179). Table 4

 
Table 4

Binary logistic regression analysis between pulmonary hemorrhage and BPD

 

aOR

95%CI

p value

All BPD*

2.647

0.879–7.968

0.083

All BPD#

3.295

1.183–9.179

0.023

Moderate to severe BPD*

2.096

0.672–6.540

0.203

Moderate to severe BPD#

2.619

0.885–7.752

0.082

*Model 1; #Model 2.


4. Discussion

Due to the smaller gestational age, lower birth weight and immature lung development, very preterm infants are vulnerable to pulmonary hemorrhage. According to reports from different centers, the incidence in VLBWI vary from 0.5–11.0%, while the mortality is as high as 50–82% [1921]. Our data showed that the incidence was 15.3% (42/275), and the mortality rate was 21.4% (9/42) in VLBWIs. Although the survival rate seems improved, longer mechanical ventilation is often needed after pulmonary hemorrhage.

Considering the lung injury caused by pulmonary hemorrhage and subsequent long-term invasive ventilation, it seems that pulmonary hemorrhage can increase the incidence of BPD. A retrospective study found that moderate to severe BPD was significantly higher in the group with massive pulmonary hemorrhage (647 VLBWIs, p < 0.05) [7]. In contrast, another study showed that no differences in moderate to severe BPD between pulmonary hemorrhage group and non-pulmonary hemorrhage group (7/17 and 40/107 ELBWIs respectively, p > 0.05) [6]. Tomaszewska M et al further performed a retrospective case-control study and found infants with oxygen dependence at 28 days in pulmonary hemorrhage group is not significantly more than infants in non-pulmonary hemorrhage group (24/29 and 17/29 VLBWIs respectively, p > 0.05) [8]. However, almost all the reports studying on the association between BPD and pulmonary hemorrhage are univariate analysis which limits the reliability of the results.

Previous study has definitely shown that severe RDS and hemodynamically significant PDA (hsPDA) are triggers of pulmonary hemorrhage [22]. And the mechanism of pulmonary hemorrhage is mainly related to pulmonary congestion, pulmonary edema and pulmonary small vessel embolism [23]. Moreover, newborns with severe RDS and hsPDA often need longer invasive ventilation, which may increase the possibility of BPD. Our univariate analysis showed that in the comparison of survival VLBWIs, pulmonary hemorrhage increased the risks of BPD (pulmonary hemorrhage group 26/33 vs non-pulmonary hemorrhage group 98/181, p = 0.008) and moderate to severe BPD (pulmonary hemorrhage group 16/33 vs non-pulmonary hemorrhage group 38/181, p = 0.037). In fact, the correlation between invasive ventilation and BPD has already been widely reported [24]. Pulmonary hemorrhage also could prolong and increase the duration and frequency of invasive ventilation (Table 3). However, through further multivariate analysis, pulmonary hemorrhage did not increase the risks of BPD (aOR = 2.647, 95%CI0.879-7.968) and moderate to severe BPD (aOR = 2.096, 95%CI0.672-6.540). But, if the interference of invasive ventilation is excluded, pulmonary hemorrhage could increase the incidence of BPD (aOR = 3.295, 95%CI1.183-9.179), but did not increase the chance of moderate to severe BPD (aOR = 2.619, 95%CI 0.885–7.752).

Limitations

We should note that the sample size of this study is not large enough. In addition, some data including coagulation function, cardiac hemodynamics are not available because of respective study design. Consequently, better designed multicenter study is still necessary.

Conclusion

In conclusion, by univariate analysis we found that PROM, tracheal intubation in the delivery room, duration of mechanical ventilation, course of invasive ventilation (≥ 3 courses), PS (> 1 dose), medically and surgically treated PDA, grade III-IV RDS, and early onset sepsis showed significant differences between pulmonary hemorrhage group and non-pulmonary hemorrhage group. By univariate analysis, pulmonary hemorrhage did not increase the risks of BPD and moderate to severe BPD.

Declarations

Ethics

This study was approved by the ethics committee of Children's Hospital of Nanjing Medical University (Number: NJCH202004037-1). The study was exempt from informed consent by the institutional review board committee due to its retrospective nature. All data were fully anonymized before further statistical analysis. All the procedures were followed in accordance with the Declaration of Helsinki.

Acknowledgements 

The authors would like to thank the parents of the patients for their understanding. 

Funding

This study has no fund support.

Conflict of Interest Disclosures 

None reported.

Authors' contributions

Jing-jing Pan wrote this paper and analyzed the data. Mei-ling Tong and Wang Jing help to analyze the data. Xiao-yu Zhou and Rui Cheng revised this paper. Yang Yang designed this study.

Consent for publication

All authors listed have read the complete manuscript and have approved submission of the paper. 

Availability of data and materials

The dataset used during this study are available from the corresponding author on reasonable request.

References

  1. Donda K, Vijayakanthi N, Dapaah-Siakwan F, Bhatt P, Rastogi D, Rastogi S. Trends in epidemiology and outcomes of respiratory distress syndrome in the United States. Pediatr Pulmonol. 2019;54(4):405-414.
  2. Fauroux B, Hascoët JM, Jarreau PH, Magny JF, Rozé JC, Saliba E, Schwarzinger M. Risk factors for bronchiolitis hospitalization in infants: A French nationwide retrospective cohort study over four consecutive seasons (2009-201≥). PLoS One. 2020;15(3):e0229766.
  3. Niesłuchowska -Hoxha A, Cnota W, Czuba B, Ruci A, Ciaciura-Jarno M, Jagielska A, Wójtowicz D, Kierach R, Dąbrowski K, Sidorowicz M, Skrzypulec-Plinta W, Wloch A, Borowski D, Węgrzyn P. A Retrospective Study on the Risk of Respiratory Distress Syndrome in Singleton Pregnancies with Preterm Premature Rupture of Membranes between 24+0 and 36+6 Weeks, Using Regression Analysis for Various Factors. Biomed Res Int. 2018;2018:7162478.
  4. Hirata K, Kimura T, Hirano S, Wada K, Kusuda S, Fujimura M; Neonatal Research Network of Japan. Outcomes of outborn very-low-birth-weight infants in Japan. Arch Dis Child Fetal Neonatal Ed. 2021;106(2):131-136.
  5. McEvoy CT, Schilling D, Go MD, Mehess S, Durand M. Pulmonary function in extremely low birth weight infants with bronchopulmonary dysplasia before hospital discharge. J Perinatol. 2021;41(1):77-83.
  6. Wang TT, Zhou M, Hu XF, Liu JQ. Perinatal risk factors for pulmonary hemorrhage in extremely low-birth-weight infants. World J Pediatr. 2020;16(3):299-304.
  7. Li J, Xia H, Ye L, Li X, Zhang Z. Exploring prediction model and survival strategies for pulmonary hemorrhage in premature infants: a single-center, retrospective study. Transl Pediatr. 2021;10(5):1324-1332.
  8. Tomaszewska M, Stork E, Minich NM, Friedman H, Berlin S, Hack M. Pulmonary hemorrhage: clinical course and outcomes among very low-birth-weight infants. Arch Pediatr Adolesc Med. 1999;153(7):715-21.
  9. Yen TA, Wang CC, Hsieh WS, Chou HC, Chen CY, Tsao PN. Short-term outcome of pulmonary hemorrhage in very-low-birth-weight preterm infants. Pediatr Neonatol. 2013;54(5):330-4.
  10. Kinsella JP, Greenough A, Abman SH. Bronchopulmonary dysplasia. Lancet. 2006;367(9520):1421-31.
  11. SUPPORT Study Group of the Eunice Kennedy Shriver NICHD Neonatal Research Network, Finer NN, Carlo WA, Walsh MC, Rich W, Gantz MG, Laptook AR, Yoder BA, Faix RG, Das A, Poole WK, Donovan EF, Newman NS, Ambalavanan N, Frantz ID 3rd, Buchter S, Sánchez PJ, Kennedy KA, Laroia N, Poindexter BB, Cotten CM, Van Meurs KP, Duara S, Narendran V, Sood BG, O'Shea TM, Bell EF, Bhandari V, Watterberg KL, Higgins RD. Early CPAP versus surfactant in extremely preterm infants. N Engl J Med. 2010;362(21):1970-1979.
  12. International Committee for the Classification of Retinopathy of Prematurity. The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol. 2005;123(7):991-9.
  13. Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr. 1978;92(4):529-34.
  14. Volpe JJ. Neurology of the Newborn. :5th ed[M]. Saunders, Philadelphia, 2008:541.
  15. Bell MJ, Ternberg JL, Feigin RD, Keating JP, Marshall R, Barton L, Brotherton T. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg. 1978;187(1):1-7.
  16. Yu Jia-lin, Yu Hui-min, He Yu, Neonatology Group of Scientific Branch of Chinese Medical Association, Infection Committee of Neonatology Branch of Chinese Medical Association. Expert consensus on diagnosis and treatment of neonatal sepsis (2019 Edition). Chinese Journal of Pediatrics. 2019;57 (4): 252-257. In Chinese
  17. Expert Group of Chinese Neonatal Resuscitation Project. Guidelines for neonatal resuscitation in China (revised in Beijing in 2016). Chinese Journal of Perinatal Medicine 2016;19(7):481-486. In Chinese
  18. Shao Xiao-mei, Ye Hong-mao, Qiu Xiao-shan. Practical Neonatology (Fifth Edition). Beijing. People's Health Publishing House, 2019. In Chinese
  19. Bhandari V, Gagnon C, Rosenkrantz T, Hussain N. Pulmonary hemorrhage in neonates of early and late gestation. J Perinat Med. 1999;27:369e75.
  20. Garland J, Buck R, Weinberg M. Pulmonary hemorrhage risk in infants with a clinically diagnosed patent ductus arteriosus: a retrospective cohort study. Pediatrics. 1994;94: 719e23.
  21. Dufourq N, Thomson M, Adhikari M, Moodley J. Massive pulmonary haemorrhage as a cause of death in the neonate e a retrospective review. S Afr Med J. 2004;94:299e302.
  22. Chen YY, Wang HP, Lin SM, Chang JT, Hsieh KS, Huang FK, Chiou YH, Huang YF; Taiwan Premature Infant Development Collaborative Study Group. Pulmonary hemorrhage in very low-birthweight infants: risk factors and management. Pediatr Int. 2012;54(6):743-7.
  23. Welde MA, Sanford CB, Mangum M, Paschal C, Jnah AJ. Pulmonary Hemorrhage in the Neonate. Neonatal Netw. 2021;40(5):295-304.
  24. Kalikkot Thekkeveedu R, Guaman MC, Shivanna B. Bronchopulmonary dysplasia: A review of pathogenesis and pathophysiology. Respir Med. 2017;132:170-177.